Filamin interactions in differentiation, invasion and disease
细丝蛋白在分化、侵袭和疾病中的相互作用
基本信息
- 批准号:8437332
- 负责人:
- 金额:$ 34.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcuteAcute Promyelocytic LeukemiaAddressAnimal ModelAnkyrin RepeatBindingBinding SitesBiochemicalBiologicalBiological AssayBiological ProcessBoxingBreastBreast Cancer CellBundlingCardiovascular systemCell AdhesionCell Differentiation processCellsCleft PalateCollagenComplexCongenital AbnormalityCongenital DisordersCongenital Heart DefectsConnective Tissue DiseasesCrystallographyCytokine Inducible SH2-Containing ProteinCytoskeletonDataDefectDiseaseDissectionEhlers-Danlos SyndromeEpithelial CellsExtracellular MatrixExtracellular Matrix DegradationF-ActinFLNC geneFamilyGelGenesGeneticHematopoieticHumanImmunoglobulin DomainIntegrin InhibitionIntegrinsInvestigationLigandsLysineMapsMatrix MetalloproteinasesMechanicsMediatingMissense MutationMolecularMuscleMuscle CellsMutationMyocardiumN-terminalNeoplasm MetastasisNeuronal Migration DisorderNeuronsPhenotypePoint MutationProcessProtein IsoformsProteinsRegulationResistanceResolutionRoleSignal TransductionSignaling ProteinSiteSkeletal MuscleSkeletonSpecificityStructureSyndromeTechniquesTestingTretinoinUbiquitinadhesion receptorbasebrain malformationcell motilitycell typedensitydisease phenotypedisease-causing mutationexperiencefibrosarcomafilamingain of functionhuman diseaseinterestloss of functionmalformationmalignant breast neoplasmmigrationmutantperiventricular heterotopiaprotein crosslinkpublic health relevancereceptorreconstitutionresponseskeletalskeletal disorderskeletal dysplasiatraffickingubiquitin-protein ligaseurinary tract obstruction
项目摘要
DESCRIPTION (provided by applicant): Continued support is requested for our investigation of the roles of filamin in cell differentiation, invasion and disease. Filamins are essential actin
crosslinking proteins composed of an N-terminal actin-binding domain followed by 24 immunoglobulin-like domains which interact with numerous cytosolic signaling proteins and transmembrane receptors. Humans have three filamin genes, encoding the widely expressed filamin A and B and largely muscle specific filamin C. Missense point mutations in filamins cause a variety of human diseases, ranging from altered neuronal migration, to cardiac and skeletal muscle defects, and a spectrum of congenital malformations generally characterized by skeletal dysplasias but also including extra-skeletal malformations such as cleft palate, cardiac defects and obstructive uropathy. The actin-binding domain is a hotspot for filamin mutations but, despite dramatic progress in understanding filamin structure and function, how filamin point mutations cause disease remains poorly understood. Furthermore, reduced filamin A expression correlates with increased breast cancer invasion and metastasis, and we recently discovered that loss of filamin increases extracellular matrix (ECM) remodeling and cell invasion. How filamin controls ECM degradation and invasion is unknown. In addition, we have shown that ASB2 (ankyrin repeat-containing protein with a suppressor of cytokine signaling box 2), part of an E3 ubiquitin ligase complex, targets filamins for rapid proteasomal degradation and we suggest that the resultant transient loss of filamin contributes to retinoic acid-induced differentiation of acute promyelocytic leukemia cells. However, the molecular basis for ASB2 function and how loss of filamin influences cell differentiation have not been elaborated. To address the important unanswered questions highlighted above we propose three specific aims which draw on our extensive experience using biochemical, cellular and structural techniques to investigate filamins. Specifically, we will: 1) Characterize the mechanism of ASB2-mediated filamin-degradation and test its role in cell differentiation; 2) Assess the role of filamins in EC remodeling and cell invasion; and 3) Identify cellular phenotypes associated with disease-associated filamin point mutations, revealing potential molecular mechanisms of disease.
描述(由申请人提供):我们对细丝蛋白在细胞分化、侵袭和疾病中的作用的研究需要持续的支持。细丝蛋白是必需的肌动蛋白
交联蛋白由 N 端肌动蛋白结合结构域和 24 个免疫球蛋白样结构域组成,这些结构域与众多胞质信号蛋白和跨膜受体相互作用。人类具有三种细丝蛋白基因,编码广泛表达的细丝蛋白 A 和 B 以及主要为肌肉特异性的细丝蛋白 C。细丝蛋白中的错义点突变会导致多种人类疾病,从神经元迁移改变到心肌和骨骼肌缺陷,以及一系列先天畸形,通常以骨骼发育不良为特征,但也包括骨骼外畸形,例如裂隙 腭、心脏缺陷和梗阻性尿路病。肌动蛋白结合域是细丝蛋白突变的热点,但是,尽管在了解细丝蛋白结构和功能方面取得了巨大进展,但细丝蛋白点突变如何导致疾病仍然知之甚少。此外,细丝蛋白 A 表达的减少与乳腺癌侵袭和转移的增加相关,我们最近发现细丝蛋白的缺失会增加细胞外基质 (ECM) 重塑和细胞侵袭。细丝蛋白如何控制 ECM 降解和侵袭尚不清楚。此外,我们还发现,作为 E3 泛素连接酶复合物的一部分,ASB2(含有锚蛋白重复序列的蛋白,具有细胞因子信号传导盒 2 的抑制子)可靶向细丝蛋白以进行快速蛋白酶体降解,我们认为由此产生的细丝蛋白的短暂损失有助于视黄酸诱导的急性早幼粒细胞白血病细胞的分化。然而,ASB2 功能的分子基础以及细丝蛋白的缺失如何影响细胞分化尚未得到详细阐述。为了解决上面强调的重要的未解答的问题,我们提出了三个具体目标,这些目标借鉴了我们使用生化、细胞和结构技术研究细丝蛋白的丰富经验。具体来说,我们将: 1)表征ASB2介导的细丝蛋白降解机制并测试其在细胞分化中的作用; 2)评估细丝蛋白在EC重塑和细胞侵袭中的作用; 3) 鉴定与疾病相关的细丝蛋白点突变相关的细胞表型,揭示疾病的潜在分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A CALDERWOOD其他文献
DAVID A CALDERWOOD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A CALDERWOOD', 18)}}的其他基金
Interaction of substrates and inhibitors with tousled-like kinase 2
底物和抑制剂与蓬乱样激酶 2 的相互作用
- 批准号:
9813105 - 财政年份:2019
- 资助金额:
$ 34.45万 - 项目类别:
2011 Fibronectin, Integrins and Related Molecules GRC/GRS
2011 纤连蛋白、整合素及相关分子 GRC/GRS
- 批准号:
8125512 - 财政年份:2011
- 资助金额:
$ 34.45万 - 项目类别:
Integrin-Filamin Interactions in Migration and Signaling
整合素-细丝蛋白在迁移和信号传导中的相互作用
- 批准号:
7931117 - 财政年份:2009
- 资助金额:
$ 34.45万 - 项目类别:
Identification of beta 1 integrin activating proteins
β1 整合素激活蛋白的鉴定
- 批准号:
7293763 - 财政年份:2007
- 资助金额:
$ 34.45万 - 项目类别:
Identification of beta 1 integrin activating proteins
β1 整合素激活蛋白的鉴定
- 批准号:
7449516 - 财政年份:2007
- 资助金额:
$ 34.45万 - 项目类别:
Integrin-filamin Interactions in Migration and Signaling
整合素-细丝蛋白在迁移和信号转导中的相互作用
- 批准号:
6928000 - 财政年份:2003
- 资助金额:
$ 34.45万 - 项目类别:
Integrin-Filamin Interactions in Migration and Signaling
整合素-细丝蛋白在迁移和信号传导中的相互作用
- 批准号:
8052740 - 财政年份:2003
- 资助金额:
$ 34.45万 - 项目类别:
相似海外基金
Elucidation of the pathophysiology of RARB translocation-positive acute promyelocytic leukemia and development of new target therapy
RARB易位阳性急性早幼粒细胞白血病病理生理学的阐明及新靶向治疗的开发
- 批准号:
19K16762 - 财政年份:2019
- 资助金额:
$ 34.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanism of action of cereblon modulators on acute promyelocytic leukemia (APL)
阐明 cereblon 调节剂对急性早幼粒细胞白血病 (APL) 的作用机制
- 批准号:
19K16378 - 财政年份:2019
- 资助金额:
$ 34.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Aberrant expression of the platelet aggregating cell surface protein podoplanin by acute promyelocytic leukemia blasts may explain the bleeding complications associated with this disease.
急性早幼粒细胞白血病母细胞血小板聚集细胞表面蛋白足足蛋白的异常表达可以解释与该疾病相关的出血并发症。
- 批准号:
362809 - 财政年份:2016
- 资助金额:
$ 34.45万 - 项目类别:
Studentship Programs
Epigenetics in differentiation of acute promyelocytic leukemia cells by synthetic retinoids
合成类视黄醇诱导急性早幼粒细胞白血病细胞分化的表观遗传学
- 批准号:
23591558 - 财政年份:2011
- 资助金额:
$ 34.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Leukemogenic property of acute promyelocytic leukemia gene, BCOR-RARA
急性早幼粒细胞白血病基因 BCOR-RARA 的致白血病特性
- 批准号:
23591410 - 财政年份:2011
- 资助金额:
$ 34.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid Label-Free Detection of Acute Promyelocytic Leukemia
急性早幼粒细胞白血病的快速无标记检测
- 批准号:
8322030 - 财政年份:2011
- 资助金额:
$ 34.45万 - 项目类别:
Mechanisms of acute promyelocytic leukemia cell infiltration and mobilization during ATRA therapy: new strategy for prevention of ATRA syndrome and additional chemotherapy.
ATRA治疗期间急性早幼粒细胞白血病细胞浸润和动员的机制:预防ATRA综合征和额外化疗的新策略。
- 批准号:
23650603 - 财政年份:2011
- 资助金额:
$ 34.45万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Rapid Label-Free Detection of Acute Promyelocytic Leukemia
急性早幼粒细胞白血病的快速无标记检测
- 批准号:
8032345 - 财政年份:2011
- 资助金额:
$ 34.45万 - 项目类别:
Efficacy of combination treatment with arsenic trioxide and all-trans retinoic acid on acute promyelocytic leukemia therapy
三氧化二砷联合全反式维A酸治疗急性早幼粒细胞白血病的疗效
- 批准号:
22790137 - 财政年份:2010
- 资助金额:
$ 34.45万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Determining commonly modulated gene targets and cellular pathways in Acute Promyelocytic Leukemia.
确定急性早幼粒细胞白血病中常见调节的基因靶标和细胞途径。
- 批准号:
184343 - 财政年份:2008
- 资助金额:
$ 34.45万 - 项目类别:
Studentship Programs














{{item.name}}会员




